rs773167797
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP6BS2
The NM_021098.3(CACNA1H):c.853G>A(p.Glu285Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000106 in 1,606,460 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000011 ( 0 hom. )
Consequence
CACNA1H
NM_021098.3 missense
NM_021098.3 missense
Scores
4
11
4
Clinical Significance
Conservation
PhyloP100: 7.49
Publications
0 publications found
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
BP6
Variant 16-1200305-G-A is Benign according to our data. Variant chr16-1200305-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 577251.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS2
High AC in GnomAdExome4 at 16 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1H | ENST00000348261.11 | c.853G>A | p.Glu285Lys | missense_variant | Exon 7 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
CACNA1H | ENST00000569107.6 | c.853G>A | p.Glu285Lys | missense_variant | Exon 7 of 34 | 1 | ENSP00000454990.2 | |||
CACNA1H | ENST00000711493.1 | c.853G>A | p.Glu285Lys | missense_variant | Exon 7 of 34 | ENSP00000518778.1 | ||||
CACNA1H | ENST00000565831.7 | c.853G>A | p.Glu285Lys | missense_variant | Exon 7 of 34 | 1 | ENSP00000455840.1 | |||
CACNA1H | ENST00000711450.1 | c.853G>A | p.Glu285Lys | missense_variant | Exon 7 of 35 | ENSP00000518762.1 | ||||
CACNA1H | ENST00000564231.6 | c.853G>A | p.Glu285Lys | missense_variant | Exon 7 of 35 | 1 | ENSP00000457555.2 | |||
CACNA1H | ENST00000638323.1 | c.814G>A | p.Glu272Lys | missense_variant | Exon 7 of 35 | 5 | ENSP00000492267.1 | |||
CACNA1H | ENST00000562079.6 | c.853G>A | p.Glu285Lys | missense_variant | Exon 7 of 34 | 1 | ENSP00000454581.2 | |||
CACNA1H | ENST00000711438.1 | c.814G>A | p.Glu272Lys | missense_variant | Exon 7 of 34 | ENSP00000518754.1 | ||||
CACNA1H | ENST00000711482.1 | c.853G>A | p.Glu285Lys | missense_variant | Exon 7 of 36 | ENSP00000518771.1 | ||||
CACNA1H | ENST00000711485.1 | c.853G>A | p.Glu285Lys | missense_variant | Exon 7 of 35 | ENSP00000518774.1 | ||||
CACNA1H | ENST00000711455.1 | c.853G>A | p.Glu285Lys | missense_variant | Exon 7 of 36 | ENSP00000518768.1 | ||||
CACNA1H | ENST00000711483.1 | c.853G>A | p.Glu285Lys | missense_variant | Exon 7 of 35 | ENSP00000518772.1 | ||||
CACNA1H | ENST00000711456.1 | c.853G>A | p.Glu285Lys | missense_variant | Exon 7 of 34 | ENSP00000518769.1 | ||||
CACNA1H | ENST00000621827.2 | n.853G>A | non_coding_transcript_exon_variant | Exon 7 of 37 | 6 | ENSP00000518766.1 | ||||
CACNA1H | ENST00000637236.3 | n.853G>A | non_coding_transcript_exon_variant | Exon 7 of 34 | 5 | ENSP00000492650.2 | ||||
CACNA1H | ENST00000639478.1 | n.853G>A | non_coding_transcript_exon_variant | Exon 7 of 35 | 5 | ENSP00000491945.1 | ||||
CACNA1H | ENST00000640028.1 | n.853G>A | non_coding_transcript_exon_variant | Exon 7 of 35 | 5 | ENSP00000491488.1 | ||||
CACNA1H | ENST00000711442.1 | n.*300G>A | non_coding_transcript_exon_variant | Exon 6 of 34 | ENSP00000518758.1 | |||||
CACNA1H | ENST00000711448.1 | n.853G>A | non_coding_transcript_exon_variant | Exon 7 of 36 | ENSP00000518760.1 | |||||
CACNA1H | ENST00000711449.1 | n.853G>A | non_coding_transcript_exon_variant | Exon 7 of 35 | ENSP00000518761.1 | |||||
CACNA1H | ENST00000711451.1 | n.853G>A | non_coding_transcript_exon_variant | Exon 7 of 36 | ENSP00000518763.1 | |||||
CACNA1H | ENST00000711452.1 | n.853G>A | non_coding_transcript_exon_variant | Exon 7 of 36 | ENSP00000518764.1 | |||||
CACNA1H | ENST00000711453.1 | n.853G>A | non_coding_transcript_exon_variant | Exon 7 of 36 | ENSP00000518765.1 | |||||
CACNA1H | ENST00000711484.1 | n.853G>A | non_coding_transcript_exon_variant | Exon 7 of 35 | ENSP00000518773.1 | |||||
CACNA1H | ENST00000711486.1 | n.853G>A | non_coding_transcript_exon_variant | Exon 7 of 37 | ENSP00000518775.1 | |||||
CACNA1H | ENST00000711487.1 | n.853G>A | non_coding_transcript_exon_variant | Exon 7 of 36 | ENSP00000518776.1 | |||||
CACNA1H | ENST00000711488.1 | n.853G>A | non_coding_transcript_exon_variant | Exon 7 of 35 | ENSP00000518777.1 | |||||
CACNA1H | ENST00000711442.1 | n.*300G>A | 3_prime_UTR_variant | Exon 6 of 34 | ENSP00000518758.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152196Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1
AN:
152196
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000211 AC: 5AN: 236484 AF XY: 0.0000310 show subpopulations
GnomAD2 exomes
AF:
AC:
5
AN:
236484
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1454264Hom.: 0 Cov.: 32 AF XY: 0.00000969 AC XY: 7AN XY: 722634 show subpopulations
GnomAD4 exome
AF:
AC:
16
AN:
1454264
Hom.:
Cov.:
32
AF XY:
AC XY:
7
AN XY:
722634
show subpopulations
African (AFR)
AF:
AC:
0
AN:
33354
American (AMR)
AF:
AC:
4
AN:
44050
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25858
East Asian (EAS)
AF:
AC:
1
AN:
39470
South Asian (SAS)
AF:
AC:
1
AN:
85204
European-Finnish (FIN)
AF:
AC:
1
AN:
51498
Middle Eastern (MID)
AF:
AC:
0
AN:
5756
European-Non Finnish (NFE)
AF:
AC:
9
AN:
1108960
Other (OTH)
AF:
AC:
0
AN:
60114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152196Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74338 show subpopulations
GnomAD4 genome
AF:
AC:
1
AN:
152196
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
74338
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41452
American (AMR)
AF:
AC:
0
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5198
South Asian (SAS)
AF:
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
1
AN:
68024
Other (OTH)
AF:
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
Jan 07, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Hyperaldosteronism, familial, type IV Uncertain:1
Oct 31, 2019
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Dec 01, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Uncertain
DANN
Pathogenic
DEOGEN2
Uncertain
D;.;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;D;D;.
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Benign
L;.;L;L
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;.;D;D
REVEL
Uncertain
Sift
Benign
T;.;T;T
Sift4G
Uncertain
T;.;D;D
Polyphen
D;.;D;D
Vest4
MutPred
Gain of methylation at E285 (P = 0.0062);.;Gain of methylation at E285 (P = 0.0062);Gain of methylation at E285 (P = 0.0062);
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.